New Enterprise Associates 15, L.P. Reneo Pharmaceuticals, Inc. (RPHM) insider trading activity

New Enterprise Associates 15, L.P. is > 10% Shareholder of Reneo Pharmaceuticals, Inc.. Currently has a direct ownership of 4.79 Million shares of RPHM, which is worth approximately $8.04 Million. The most recent transaction as insider was on Apr 13, 2021, when has been sold 666,666 shares (Common Stock) at a price of $15.0 per share, resulting in proceeds of $9,999,990. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.79M

0% 3M change

0% 12M change

Total Value Held $8.04 Million

New Enterprise Associates 15, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 13 2021	BUY Open market or private purchase	$9,999,990 $15.0 p/Share	666,666 Added 12.23%	4,785,494 Common Stock
Apr 13 2021	BUY Conversion of derivative security	-	4,118,828 Added 50.0%	4,118,828 Common Stock

Also insider at

EAR

Eargo, Inc. Healthcare

> 10% Shareholder

Desktop Metal, Inc. Technology

> 10% Shareholder

BHG

Bright Health Group Inc. Healthcare

HOOD

Robinhood Markets, Inc. Technology

Director

ACLX

Arcellx, Inc. Healthcare

> 10% Shareholder

IONQ

IonQ, Inc. Technology

> 10% Shareholder

AVEO

AVEO PHARMACEUTICALS, INC. Healthcare

> 10% Shareholder

BGRY

Berkshire Grey, Inc. Industrials

> 10% Shareholder

NEA